Search Results
U1149 – University Paris Diderot, Paris, France
Search for other papers by J Cros in
Google Scholar
PubMed
Search for other papers by O Hentic in
Google Scholar
PubMed
Department of Gastroenterology and Pancreatology, AP-HP, DHU UNITY, Beaujon University Hospital, Clichy, France
Search for other papers by V Rebours in
Google Scholar
PubMed
Search for other papers by M Zappa in
Google Scholar
PubMed
Search for other papers by N Gille in
Google Scholar
PubMed
Search for other papers by N Theou-Anton in
Google Scholar
PubMed
Search for other papers by D Vernerey in
Google Scholar
PubMed
Search for other papers by F Maire in
Google Scholar
PubMed
Department of Gastroenterology and Pancreatology, AP-HP, DHU UNITY, Beaujon University Hospital, Clichy, France
Search for other papers by P Lévy in
Google Scholar
PubMed
U1149 – University Paris Diderot, Paris, France
Search for other papers by P Bedossa in
Google Scholar
PubMed
U1149 – University Paris Diderot, Paris, France
Search for other papers by V Paradis in
Google Scholar
PubMed
Department of Digestive Oncology, AP-HP, DHU UNITY, Beaujon University Hospital, Clichy, France
Search for other papers by P Hammel in
Google Scholar
PubMed
Department of Gastroenterology and Pancreatology, AP-HP, DHU UNITY, Beaujon University Hospital, Clichy, France
Search for other papers by P Ruszniewski in
Google Scholar
PubMed
Department of Pathology, AP-HP, DHU UNITY, Bichat University Hospital, Paris, France
Search for other papers by A Couvelard in
Google Scholar
PubMed
predict the efficacy of TEM in other tumor types ( Hegi et al. 2005 , Schraml et al. 2012 ). There is no consensus on how to best assess MGMT. Methylation of MGMT promoter was associated with a prolonged overall survival in patients with
Search for other papers by Marijn A Vermeulen in
Google Scholar
PubMed
BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands
Search for other papers by Carolien H M van Deurzen in
Google Scholar
PubMed
Search for other papers by Shusma C Doebar in
Google Scholar
PubMed
Search for other papers by Wendy W J de Leng in
Google Scholar
PubMed
Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands
Search for other papers by John W M Martens in
Google Scholar
PubMed
Search for other papers by Paul J van Diest in
Google Scholar
PubMed
Search for other papers by Cathy B Moelans in
Google Scholar
PubMed
et al. 2010 , Kornegoor et al. 2012 a , b , Lacle et al. 2013 ). Epigenetic changes, including DNA methylation, play an essential role in carcinogenesis besides established players such as mutations, copy number changes and genetic
Search for other papers by Kristina Warton in
Google Scholar
PubMed
Garvan Institute of Medical Research, Chris O'Brien Lifehouse, The Kinghorn Cancer Centre and St Vincent's Clinical School, 370 Victoria Street, Darlinghurst, Sydeny, New South Wales, Australia
Search for other papers by Kate L Mahon in
Google Scholar
PubMed
Search for other papers by Goli Samimi in
Google Scholar
PubMed
treatment. ctDNA can be distinguished from circulating DNA from healthy cells by the presence of genomic aberrations that correspond to those found in the tumor, such as tumor-specific mutations or methylation. The feasibility of using tumor
Consortium for the Study of Thyroid Cancer (CECaT), Catalonia, Spain
Search for other papers by Carles Zafon in
Google Scholar
PubMed
Search for other papers by Joan Gil in
Google Scholar
PubMed
Search for other papers by Beatriz Pérez-González in
Google Scholar
PubMed
Program of Predictive and Personalized Medicine of Cancer, Germans Trias i Pujol Research Institute (PMPPC-IGTP), Barcelona, Spain
Search for other papers by Mireia Jordà in
Google Scholar
PubMed
phenotypes. There are several epigenetic mechanisms: DNA methylation, posttranslational modifications of histones, chromatin remodeling or non-coding RNAs. These mechanisms have been reviewed elsewhere ( Bannister & Kouzarides 2011 , Holoch & Moazed 2015
Search for other papers by Laura M S Seeber in
Google Scholar
PubMed
Search for other papers by Ronald P Zweemer in
Google Scholar
PubMed
Search for other papers by Luigi Marchionni in
Google Scholar
PubMed
Search for other papers by Leon F A G Massuger in
Google Scholar
PubMed
Search for other papers by Vincent T H B M Smit in
Google Scholar
PubMed
Search for other papers by W Marchien van Baal in
Google Scholar
PubMed
Search for other papers by René H M Verheijen in
Google Scholar
PubMed
Search for other papers by Paul J van Diest in
Google Scholar
PubMed
Introduction Tumours presumably develop by a stepwise accumulation of interacting epigenetic and genetic events over time ( Baylin & Herman 2000 , Jones & Baylin 2002 ). Promoter methylation is an epigenetic event that plays an important role in
Search for other papers by Charles E Massie in
Google Scholar
PubMed
Search for other papers by Inmaculada Spiteri in
Google Scholar
PubMed
Search for other papers by Helen Ross-Adams in
Google Scholar
PubMed
Search for other papers by Hayley Luxton in
Google Scholar
PubMed
Search for other papers by Jonathan Kay in
Google Scholar
PubMed
Search for other papers by Hayley C Whitaker in
Google Scholar
PubMed
Search for other papers by Mark J Dunning in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by Alastair D Lamb in
Google Scholar
PubMed
Search for other papers by Antonio Ramos-Montoya in
Google Scholar
PubMed
Search for other papers by Daniel S Brewer in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by Colin S Cooper in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by Rosalind Eeles in
Google Scholar
PubMed
Search for other papers by UK Prostate ICGC Group in
Google Scholar
PubMed
Search for other papers by Anne Y Warren in
Google Scholar
PubMed
Search for other papers by Simon Tavaré in
Google Scholar
PubMed
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Cancer Research UK Cambridge Institute, Division of Genetics and Epidemiology, Department of Biological Sciences and School of Medicine, Royal Marsden NHS Foundation Trust, Departments of Pathology, Urology, Surgical Oncology, University of Cambridge, Cambridge, CB2 0RE, UK
Search for other papers by David E Neal in
Google Scholar
PubMed
Search for other papers by Andy G Lynch in
Google Scholar
PubMed
( Supplementary Figure 1 a). These samples were used for global methylation profiling using Infinium HumanMethylation450 arrays (see below for details). Figure 1 HES5 promoter methylation is an early event in prostate tumourigenesis. (A) Representation of
Search for other papers by I Marinoni in
Google Scholar
PubMed
Search for other papers by A Wiederkeher in
Google Scholar
PubMed
GCB Graduate School Bern, Bern, Switzerland
Search for other papers by T Wiedmer in
Google Scholar
PubMed
Search for other papers by S Pantasis in
Google Scholar
PubMed
GCB Graduate School Bern, Bern, Switzerland
Search for other papers by A Di Domenico in
Google Scholar
PubMed
Search for other papers by R Frank in
Google Scholar
PubMed
Search for other papers by E Vassella in
Google Scholar
PubMed
Search for other papers by A Schmitt in
Google Scholar
PubMed
Search for other papers by A Perren in
Google Scholar
PubMed
) ). DAXX and ATRX participate in maintaining the epigenetic status of the cells by regulating both DNA methylation and H3.3 deposition at telomeric and peri-centromeric regions. DAXX interacts and recruits DNA methyl-transferase enzyme 1 (DNMT1) to specific
Search for other papers by Ana Carolina Bueno in
Google Scholar
PubMed
Search for other papers by Rui M P da Silva in
Google Scholar
PubMed
Search for other papers by Mônica F Stecchini in
Google Scholar
PubMed
Search for other papers by Junier Marrero-Gutiérrez in
Google Scholar
PubMed
Department of Computation and Mathematics, Faculty of Philosophy, Sciences and Letters at Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
Search for other papers by Danillo C de Almeida e Silva in
Google Scholar
PubMed
Search for other papers by Izilda Cardinalli in
Google Scholar
PubMed
Search for other papers by Carlos Alberto Scrideli in
Google Scholar
PubMed
Search for other papers by Thais Junqueira in
Google Scholar
PubMed
Search for other papers by Carlos A F Molina in
Google Scholar
PubMed
Search for other papers by Fernando Silva Ramalho in
Google Scholar
PubMed
Search for other papers by Silvio Tucci Jr in
Google Scholar
PubMed
Search for other papers by Fernanda Borchers Coeli-Lacchini in
Google Scholar
PubMed
Search for other papers by Ayrton Custodio Moreira in
Google Scholar
PubMed
Search for other papers by Leandra N Z Ramalho in
Google Scholar
PubMed
Search for other papers by Silvia Brandalise in
Google Scholar
PubMed
Search for other papers by José Andres Yunes in
Google Scholar
PubMed
Search for other papers by Margaret de Castro in
Google Scholar
PubMed
Search for other papers by Ricardo Zorzetto Nicoliello Vêncio in
Google Scholar
PubMed
Search for other papers by Sonir R R Antonini in
Google Scholar
PubMed
have prognostic relevance but once accumulated, represent a complex interplay in patients with unfavorable outcomes ( Pinto et al. 2015 ). Recent genome-wide studies demonstrated the prognostic relevance of ACT methylation profiling. In tumors from
Search for other papers by Takaya Kodama in
Google Scholar
PubMed
Search for other papers by Kenji Oki in
Google Scholar
PubMed
Search for other papers by Yu Otagaki in
Google Scholar
PubMed
Search for other papers by Ryuta Baba in
Google Scholar
PubMed
Search for other papers by Akira Okada in
Google Scholar
PubMed
Search for other papers by Kiyotaka Itcho in
Google Scholar
PubMed
Search for other papers by Kazuhiro Kobuke in
Google Scholar
PubMed
Search for other papers by Gaku Nagano in
Google Scholar
PubMed
Search for other papers by Haruya Ohno in
Google Scholar
PubMed
Search for other papers by Nobuyuki Hinata in
Google Scholar
PubMed
Search for other papers by Koji Arihiro in
Google Scholar
PubMed
Department of Pharmacology & Toxicology, University of Mississippi Medical Center, Jackson, Mississippi, USA
Search for other papers by Celso E Gomez-Sanchez in
Google Scholar
PubMed
Search for other papers by Masayasu Yoneda in
Google Scholar
PubMed
Search for other papers by Noboru Hattori in
Google Scholar
PubMed
CTNNB1 mutations is associated with tumorigenesis ( Goh et al. 2014 , Baba et al. 2021 ). Gene transcription is regulated by transcription factors and epigenetic changes in the gene. DNA methylation involves the transfer of a methyl group onto
Search for other papers by S G Creemers in
Google Scholar
PubMed
Search for other papers by P M van Koetsveld in
Google Scholar
PubMed
Search for other papers by F J van Kemenade in
Google Scholar
PubMed
Department of Histopathology, King’s College Hospital, Denmark Hill, London, UK
Search for other papers by T G Papathomas in
Google Scholar
PubMed
Search for other papers by G J H Franssen in
Google Scholar
PubMed
Search for other papers by F Dogan in
Google Scholar
PubMed
Search for other papers by E M W Eekhoff in
Google Scholar
PubMed
Search for other papers by P van der Valk in
Google Scholar
PubMed
Search for other papers by W W de Herder in
Google Scholar
PubMed
Search for other papers by J A M J L Janssen in
Google Scholar
PubMed
Search for other papers by R A Feelders in
Google Scholar
PubMed
Search for other papers by L J Hofland in
Google Scholar
PubMed
( Schmitt et al . 2006 , Wang et al . 2014 ). By the concept of DNA methylation, several factors are supposed to regulate IGF2 expression ( Fig. 1 ). Figure 1 Overview of the imprinted region of the IGF2 gene and H19 gene on the maternal and